Hydromorphone (Dilaudid) and Ketamine Therapy | Tovani Health
Dilaudid (Hydromorphone) — Potent opioid analgesic (mu-receptor agonist)
Verdict at Tovani Health
Compatible with the same close-monitoring approach used for other potent opioids.
Hydromorphone and ketamine are compatible with appropriate monitoring. Hydromorphone is several times more potent than morphine, so the respiratory-depression considerations sit between standard opioids and fentanyl. We coordinate closely with the pain prescriber.
If you take Dilaudid regularly and are considering at-home ketamine therapy, the combination is safe with monitoring or dose adjustment. This page covers the brief pharmacologic context and what we do at intake.
How Dilaudid interacts with ketamine
Hydromorphone is a semi-synthetic mu-opioid agonist. Higher potency means smaller absolute doses but proportionally greater respiratory risk when stacked with ketamine.
What we do at intake
Disclose dose, formulation, and indication. We plan session timing carefully and may modify protocol for at-home settings.
Bottom line
Hydromorphone and ketamine are compatible with appropriate monitoring. Hydromorphone is several times more potent than morphine, so the respiratory-depression considerations sit between standard opioids and fentanyl. We coordinate closely with the pain prescriber.
Frequently Asked Questions
Is Dilaudid different from morphine for KAP planning?
Same principles, higher potency. We plan the session around your specific dose.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Dilaudid (Hydromorphone) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Sources
The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.
- Ketamine as an adjuvant to opioids for cancer pain. Bell RF, Eccleston C, Kalso EA.. Cochrane Database of Systematic Reviews. 2017. PMID: 28657160
Cochrane systematic review evaluating ketamine added to opioid therapy for cancer pain.
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism. Williams NR, Heifets BD, Blasey C, et al.. American Journal of Psychiatry. 2018. PMID: 30153752
Landmark study showing pretreatment with naltrexone (opioid receptor antagonist) blocks the antidepressant effect of ketamine.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 16, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.